Nanoparticles (NPs) apart from their widespread advantages and increased utilisation, have aroused concerns over their safe use. Nickel (II) oxides (NiO) NPs are used as catalysts, biosensors and in many of the consumer products. The increasing use of NiO NPs necessitates an improved understanding of their potential impact on the environment and human health. In this study, we investigated the acute genotoxic effects of NiO NPs by oral route administration with three different doses (125, 250 and 500 mg/kg bw). Before the in vivo toxicological evaluation, characterisation of particles by Transmission Electron Microscopy, X-ray diffraction, Dynamic Light Scattering (DLS) and Laser Doppler Velocimetry analysis was performed. Genotoxicity biomarkers such as comet, micronucleus and chromosomal aberrations (CAs) assays were utilised in this study. To document the uptake, retention and elimination of the NPs, biodistribution studies were also performed. The particle size obtained from Transmission Electron Microscopy analysis for NiO NPs was 15.62 ± 2.59 nm. The mean hydrodynamic diameter and PdI of NiO NPs in Milli-Q water suspension obtained by DLS was 168.9 ± 17.13 nm and 0.375, respectively. Comet assay revealed significant (P < 0.001) DNA damage at 500 mg/kg bw dose in the PBL, liver and kidney cells of rats at the 24-h sampling time. The result of micronucleus and CAs tests was in agreement with the comet assay data. Biodistribution of NiO NPs revealed a maximum accumulation of Ni in the liver tissue at the 24-h sampling time. Our study showed significant DNA damage at the high dose level and the effect was more prominent at 24-h sampling time, providing preliminary evidence that the NiO NPs are capable of inducing genotoxicity when administered through the oral route. However, mechanistic investigations are needed before drawing any firm conclusion regarding the toxicology of NiO NPs.
Introduction
Nanoparticles (NPs) have gained considerable international attention due to their widespread advantages ranging from aerospace engineering and nanoelectronics to environmental remediation and medical healthcare. NPs have a variety of physicochemical and electronic features such as bigger specific surface area and high surface reactivity as a function of their size in comparison to the corresponding microparticles (MPs) (1) . The special characteristics of NPs also include increased reactivity and enhanced ability to enter tissues and cell membranes (2) . The rapid development and increased utilisation of nanomaterials (NMs) worldwide have raised concerns of toxicologists regarding their safe use (3, 4) . Previous investigations revealed that NPs are absorbed as they move through the gastrointestinal tract and get distributed to different organs including liver via the circulatory system. Studies have shown that upon oral administration of NPs to mice, they get accumulated in the liver and caused toxicity (5) (6) (7) . The NPs could enter into the human gastrointestinal tract accidentally through ingestion during their manufacture or by consumption of water or food contaminated with NPs (8, 9) . Recent studies suggest that NPs induced overproduction of reactive oxygen species (ROS) and oxidative stress which might be the possible mechanisms of their toxicity (8, 10, 11) . Among the different NPs, metal oxide NPs are the most often utilised NMs in consumer goods.
Nickel (II) oxide (NiO) is notable as being the only well-characterised oxide compound of nickel (12) . The International Agency for Research on Cancer (IARC Monographs) on the evaluation of carcinogenic risks to humans has grouped nickel (Ni) compounds as Class 1 carcinogenic material (13) . Further, NiO is categorised as a compound with relatively low toxicity in comparison to other Ni compounds (14, 15) . NiO NPs are used in different applications such as catalysts, light-emitting diodes, lithium-ion batteries, solar cells, electrochemical sensors and biosensors (16, 17) . NiO has attracted considerable attention for as a catalyst for the decomposition of hazardous dyes (18) . The increasing use of NiO NPs necessitates an improved understanding of their potential impact on the environment and human health. The mechanisms how NiO NPs produce toxicity are still elusive. Recently, a study reported that exposure to high levels of Ni had significantly lowered the levels of antioxidants which in turn reduced serum anti-oxidative capacity (19) . Studies have been conducted on NiO NPs that show toxicity to microorganisms such as algae, bacteria and plants like tomato seedlings roots (20) (21) (22) . NiO NPs caused cytotoxicity via ROS and induced apoptosis in HepG 2 cells, which is likely to be mediated through bax/bcl-2 pathway (23) . The cytotoxicity and apoptotic effects of NiO NPs on human cervix epithelioid carcinoma cell line (HeLa) showed significant dose-dependent toxicity (24) . In mammalian systems, toxic effects of NiO NPs have been investigated, mainly on airway cells (25, 26) . Inflammation induced lung toxicity following intratracheal instillation of NiO NPs in rats was well documented (27) (28) (29) . Abudayyak et al. (30) indicated the cellular toxic effects of NiO NPs have increased the concerns about the safety associated with their applications in consumer products.
Although in vitro studies enable elucidation of the mechanism of toxicity, in vitro results should be confirmed by in vivo studies for hazard assessment. No study, so far, has investigated NiO NPs toxicity in rats after acute oral exposure. Hence, in this study, we attempted to investigate genotoxic effects of NiO NPs with three different doses by oral route administration. Appropriate characterisation of NPs consists of measurements such as size and size distribution, surface area, shape and other morphological features (31) . The size of NPs may be one of the main factors that could affect the interactions of NPs with the biological systems for absorption, distribution, metabolism and excretion (32) . The tiny size and large surface area of the NPs make it easier for them to enter the epithelial cells and the blood circulation to reach the target sites (33, 34) . Hence, characterisation of particles was performed using Transmission Electron Microscopy (TEM), Brunauer-Emmett-Teller (BET), X-Ray Diffraction (XRD), Dynamic Light Scattering (DLS) and Laser Doppler Velocimetry (LDV) before the initiation of the toxicological studies in the current investigation.
Acute oral toxicity study of NiO NPs was conducted following Organisation for Economic Cooperation and Development guidelines 420 (35) . Genotoxicity assays were primarily devised for evaluating the structural or numerical damage caused by chemicals which could be associated with progression of tumours or developmental disorders in test models (36) . Genotoxicity biomarkers are available for the studies of environmental risk assessment and DNA damage (37, 38) . Particles which are less than 100 nm, are capable of entering cells and attach to macromolecules such as DNA and proteins (39) leading to DNA damage. Hence, the comet, micronucleus and CAs assays were utilised in this study to depict the genotoxicity of NiO NPs. NPs have different rates of absorption, persistence, distribution, accumulation and elimination patterns when compared to MPs resulting in a potent interaction with animal models (2) . Therefore, to understand the uptake, retention, and elimination of NiO NPs, biodistribution studies were also performed. 
Materials and methods

Nanoparticles and chemicals
Characterisation of NiO NPs
The particles were characterised using TEM, BET, XRD, DLS and LDV to evaluate the size of the material, surface area, size distribution, dispersion state and zeta potential of the NPs in Milli-Q water. Size and morphology of NiO NPs were assessed using TEM (JEM-2100, JEOL, Japan). The suspension of NiO NPs in Milli-Q water was prepared at a concentration of 0.01 mg/ml and one drop of suspension was placed on TEM grid (carbon-coated copper grid) and allowed to evaporate at room temperature. The images of the NPs were captured with the help of camera attached to the TEM instrument. For the size measurement, 100 particles were calculated from random fields of view and images showing the general morphology of the particles. The specific surface area of the NiO NPs was measured by the BET method by using the Surface Area and Pore Size Analyzer SA 3100 plus (Beckman Coulter, USA). The hydrodynamic size and surface charge of the NiO NPs in Milli-Q water suspension was measured through DLS and LDV using a Malvern Zetasizer Nano-ZS (Malvern Instruments, UK). The suspension of freshly prepared NiO NPs in Milli-Q water at the concentration of 40 µg/ml was ultra-sonicated using a probe sonicator (UPH 100, Germany) for 10 min at 90% amplitude. One ml of the suspension was used for LDV measurements by transferring to a Malvern Clear Zeta Potential cell. The polydispersity index (PdI) was used to measure the size in the solution. In general, PdI scale will have a range from 0 to 1, and 0 corresponds to mono dispersion state whereas, 1 corresponds to poly dispersion state of the particles.
Animals
Female albino Wistar rats weighing between 80 and 120 g were procured from the National Institute of Nutrition, Hyderabad, India. Before initiation of the experiments, acclimatisation of the rats for 1 week was carried out. Five animals were kept in each of the polypropylene cages. The animals were given a diet of standard laboratory pellet and provided ad libitum supply of tap water. The rats were maintained at a temperature of (22 ± 3 ○ C) and light (12 h light/12 h dark cycles) and humidity (55-65%). The study protocol was submitted to the Institutional Animal Ethics Committee. It was approved and given an ethical clearance number of IICT/BIO/TOX/ PG/12/06/2014/13.
Acute oral toxicity study
The acute oral toxicity of NiO NPs was evaluated according to the OECD guideline 420, the 'acute oral toxicity-fixed dose method' (35) . As per the protocol, for the sighting study, a single rat was administered with 5 mg/kg body weight (bw) dose. In the case of no adverse symptoms and mortality, a second rat was treated with a 50 mg/kg bw dose, followed by 300 mg/kg bw dose and finally a dose of 2000 mg/kg bw in a sequential manner. Feed was not provided to the rats prior to dosing. There was no mortality or apparent toxic symptoms at any of the dose levels in the sighting study. Hence, with a dose of 2000 mg/kg bw, a limit test was carried out with four female rats for NiO NPs. The dosed rats were observed for 14 days after treatment. The bw and feed intake were documented once a day throughout the 14-day period. Mortality, adverse symptoms and signs, were noted twice on the day of dosing and once daily after that. After 14 days observation, bw of rats was measured and then sacrificed for necropsy studies. Brain, Heart, liver, kidneys and spleen tissues were dissected for relative organ weights and histopathological studies.
Histopathological evaluation
Histopathological studies were conducted in the different organs of female rats after acute treatment with 5, 50, 300 and 2000 mg/kg bw NiO NPs to monitor the alterations in the tissues. The tissues were rinsed in 1% ice-cold saline and kept in 10% neutral buffered formalin for fixation. The fixed tissues were processed, embedded in paraffin blocks, sliced into ribbons of 2-3 µm thick sections and mounted on a glass microscope slide. The slides were stained with haematoxylin and eosin (H & E) and examined with Nikon Eclipse E 80 microscope at ×400 magnification. A minimum of three random sections per slide and three different fields of view was analysed for histopathological damage.
Experimental design: genotoxicity and biodistribution studies
The rats were divided into three groups, a positive control (for the genotoxicity studies), negative control and experimental groups. To assess the genotoxicity and biodistribution, experimental groups were further divided into three different subgroups for treatment with NiO NPs (125, 250 and 500 mg/kg bw). All the groups consisted of five animals per test per sampling time. The doses of NiO NPs were prepared in Milli-Q water after sonication using a probe sonicator for 10 min at 90% amplitude. The control groups received 2 ml/kg bw of Milli-Q water through oral gavage. CP was used as positive control at a dose of 40 mg/kg bw and injected intraperitoneally (ip). All the rats were treated with a single dose and were sacrificed by cervical dislocation at the sampling times of 18 and 24 h.
Comet assay
For the evaluation of DNA damage in the rats after acute exposure to the NiO NPs, the alkaline comet assay was conducted as per the method of Tice et al. (40) with slight modifications. Whole blood, liver and kidney tissue samples from rats were obtained at 18 and 24 h after dosing. Blood was withdrawn in EDTA-coated tubes from retro-orbital plexus of rats. Comet assay in liver and kidney tissues were carried out according to Pant et al. (41) The tissues were isolated from the rats after sacrificing at the specified time intervals, minced and suspended at ∼100 mg/ml in chilled homogenising buffer (pH 7.5) and homogenised gently at a speed of 500-800 rpm. Cell viability was determined by the trypan blue exclusion assay. Ten microlitres of whole blood, liver and kidney cell suspensions was used for the preparation of each slide and three slides were prepared per tissue for each rat. Briefly, 10 µl of blood/cell suspension was mixed in 120 µl of 0.5% LMA in PBS and embedded in between the layers of NMA (0.75%) and LMA (0.5%) on a microscopic slide and covered with a coverslip and allowed to solidify overnight at 37 ○ C. The coverslip was then removed, and slides were immersed in chilled lysis buffer (2.5 M NaCl, 0.1 M Na 2 EDTA, 0.2 M NaOH, 1% Triton X-100, 10% DMSO, pH 10.0) at 4
○ C for about 10 h. Electrophoresis was carried out at 25 V, adjusted at 300 mA for 20 min after the unwinding of DNA material for 20 min in alkaline buffer (10 M NaOH, 200 mM Na 2 EDTA, pH > 13.0) was done. Neutralisation was performed twice in 0.4 M Tris buffer, pH 7.5, for 5 min and once in methanol. The slides were stained with ethidium bromide (20 µg/ml) and then scored blind to avoid bias using a fluorescence microscope (Olympus, Shinjuku-ku, Tokyo, Japan). Fifty randomly selected cells per slide (150 cells per tissue per rat) were analysed to estimate the amount of DNA damage and expressed as the percentage of DNA in the comet tail. Quantification of DNA breakage was carried out by using CASP software version 1.2.2 (Comet Assay Software, CaspLab) to calculate the amount of DNA damage and expressed as a percentage of DNA in the comet tail.
Micronucleus test
The Micronucleus test (MNT) in the rat bone marrow cells was carried out following the method described by Schmid (42) , with some modifications. The bone marrow cells were extracted from the thigh bone of rats at 18 and 24 h after acute oral exposure to NiO NPs. The bone marrow was removed from both femurs by aspiration into a hypotonic solution consisting of 1% sodium citrate and centrifuged at approximately 1000 rpm for 5 min. The cell pellet was resuspended in a 0.5 ml of 1% sodium citrate, and a smear was prepared on a microscope slide and allowed to air dry in humidified chamber overnight. The slides were immersed in methanol for 2 min for fixation and then stained with 0.5% Giemsa (prepared in PBS) for 10 min. The stained slides were used for the measurement of the occurrence of micronucleus (MN). Slides were made in triplicate for each animal at all sampling times. The slides were microscopically analysed at ×1000 magnification. 2000 polychromatic erythrocytes (PCEs) per animal were selected from three slides, and the frequencies of micronucleated PCEs (MN-PCEs) were documented. To determine the ratio of PCEs to normochromatic erythrocytes (NCEs) in the bone marrow cells, 1000 cells from each animal were examined and the ratio was expressed as the percentage: (PCEs × 100/PCEs + NCEs).
Chromosomal aberration assay
The method described by OECD guideline 1975(43) and Adler et al. (44) was used for CA analysis with slight modifications. The analysis was performed at 18 and 24 h after oral treatment with the various doses (125, 250, 500 mg/kg bw) of NiO NPs in female Wistar rats. Since the analysis of CAs is carried out in metaphases, cell division was arrested with a mitotic inhibitor colchicine (0.02%) administered ip (a dose of 0.01 ml/g bw), 2 h prior to sacrifice. The bone marrow was collected from both femur and tibia bones in a hypotonic solution of 0.56 % potassium chloride and centrifuged at 2000 rpm for 10 min. Cells were then fixed with three changes of ice-cold Carnoy's solution (methanol: acetic acid, 3:1 v/v). After overnight refrigeration, cells were centrifuged and resuspended in fresh fixative i.e. Carnoy's solution. Few drops of the final cell suspension were dropped from a height of 15-20 inches on a chilled slide. The slides were dried on a warm plate at 40 ○ C. Three slides for each animal were prepared in triplicate and stained with 1% Giemsa for 10 min. Randomly selected 100 well-spread metaphases per animal (500 per dose) were used to count the number of CAs. Thousand cells were screened to determine the mitotic index (MI).
Nickel content analysis in different tissues, blood, urine and faeces A biodistribution study of the NiO NPs in the female Wistar rats was carried out in whole blood, brain, heart, liver, kidneys, spleen, faeces and urine. The animals were placed in metabolic cages before treatment for collecting the urine and faeces samples which were collected after 18 and 24 h after dosing. The samples were processed according to the protocol of Gómez et al. (45) The nitric acid digested samples were heated at 80 ○ C for 10 h, and additionally heated again at 130-150 ○ C for 30 min. Subsequently, 70% perchloric acid (0.5 ml) was added, the samples were then again heated for 4 h and evaporated to dryness. Following digestion with 2% HNO 3 , the samples were filtered, and a final volume of up to 5 ml was made with 2% HNO 3 for analysis. The standard solution of Ni was serially diluted to 100, 50, 10, 1 ppm. The wavelength of 221.647 nm was found to get the intensity of the samples. The Ni content in the samples was determined using ICP-OES (JY Ultima, Jobin Vyon, France).
Statistical analysis
The statistically significant changes between treated and control groups were analysed by two-way ANOVA. All the results were expressed as the mean and standard deviation (mean ± SD) of the mean. Multiple pair-wise comparisons were done using the Bonferroni post-test to compare replicate means by row and Students 't' test was used to denote the significance of positive response. Statistical analysis was performed using Graph Pad Prism 5 Software package for windows (GraphPad Software, Inc., La Jolla, CA, USA). The statistical significance for all tests was set at P < 0.05.
Results
Characterisation of NiO NPs
The physical characteristics of NiO NPs were determined by TEM, BET, DLS and LDV analysis. The mean size of NiO NPs was calculated using TEM by measuring over 100 particles in a random field. The size obtained for NiO NPs was 15.62 ± 2.59 nm (Figure 1a) . The selected area electron diffraction (SAED) patterns of the NiO NPs showed ring-like diffraction pattern which indicated the crystalline nature of the NPs. The diffraction circles could be indexed on the basis of the face centered cubic (fcc) structure of Ni. The five rings occurred due to reflections from (111), (200) in Milli-Q water were determined by LDV and was found to be +36.3 mV and 2.848 ± 0.341 µm cm/s V, respectively, at pH 7.0.
Animal observation, food consumption, body weight and organ weight
The female Wistar rats were orally administered with the 5, 50, 300 and 2000 mg/kg bw doses of NiO NPs and no adverse signs and mortality were observed after 14 days of treatment. However, rats treated with 2000 mg/kg bw of NiO NPs showed dullness, irritation and moribund symptoms and a non-significant reduction in feed intake, bw gain and relative organ weight (data not shown). Mortality was not observed in rats receiving single doses of 2000 mg/kg bw of NiO NPs. Hence, the acute toxicity of NiO NPs was greater than 2000 mg/kg bw, ranking these substances into category V, as per OECD guideline 420 and the globally harmonised system.
Histopathological examinations
The slides of rat tissues such as brain, heart, liver, spleen and kidneys stained with H & E were studied. All the organs were evaluated for any toxic changes as well as the presence of any extraneous material deposits. Liver tissues obtained from rats treated with a single dose of 2000 mg/kg bw of NiO NPs, showed tissue damage and focal areas of necrosis (Figure 2c ). In kidneys apart from few necrotic tissue regions, significant histopathological changes were not observed. There were no morphological changes in spleen, heart and brain tissues with 2000 mg/kg bw (data not shown). The sections of liver and kidneys of control rats are shown in Figure 2a and b, whereas the liver and kidneys of rats receiving 2000 mg/kg bw dose are shown in Figure 2c and d, respectively. The rats exposed to 5, 50 and 300 mg/ kg bw of NiO NPs exhibited the normal architecture of liver, kidneys, spleen, brain and heart tissues. Moreover, extraneous material deposition was not found in the examined tissues.
Genotoxicity analysis
Comet assay
The findings of the comet assay after acute oral treatment with 125, 250 and 500 mg/kg bw doses of NiO NPs are depicted in Table 1 . In all samples, the cell viability by the trypan blue exclusion technique was >90% (data not shown). There was significant (P < 0.001) increase in % tail DNA at 500 mg/kg bw dose in the PBL, liver and kidney cells of rats at the 24-h sampling time. At the 250 mg/kg bw dose, significant (P < 0.01) DNA damage was observed at both the sampling periods in kidney cells whereas at 24 h only in PBL. On the other hand, the mean % tail DNA in CP treated positive control rats was highly significant (P < 0.001) when compared with the control.
Micronucleus test
The bone marrow MNT was conducted after 18 and 24 h of oral treatment with 125, 250 and 500 mg/kg bw dose of NiO NPs in female Wistar rats. After 24 h the MNT data indicated statistically significant (P < 0.01) increment in MN-PCEs frequency in the NiO NPs treated groups with 250 and 500 mg/kg bw doses in rats. On the other hand, the CP (40 mg/kg bw) treated group induced a substantially significant (P < 0.001) effect on MN-PCEs frequency. The positive control rats treated with CP induced very significant changes in MN-PCEs and % PCEs as well (Table 2) .
Chromosomal aberration assay
The results of the CA assay examined at 18 and 24 h after the oral administration of NiO NPs with various doses (125, 250 and 500 mg/ kg bw) to female Wistar rats in bone marrow cells are shown in Tables 3  and 4 , respectively. The MI did not reveal any statistical differences (P > 0.05) between the various treatments (500, 250 and 125 mg/kg bw of NiO NPs) and control groups. The NiO NPs induced significant CAs at 500 mg/kg bw dose at both time periods of exposure. Moreover, there was a dose-dependent increase in numerical and structural changes. Total cytogenetic changes and aneuploidy were observed in bone marrow cells of NiO NPs treated rats at 500 and 250 mg/kg bw dose after single exposure at 24 h. The increase in aneuploidy was less significant (P < 0.05) at both 500 and 250 mg/kg bw doses. However, there were no changes in polyploidy level and reciprocal translocations. The MI was used to deduce the rate of cell division.
Tissue biodistribution of NiO NPs
The biodistribution levels of Ni after acute oral exposure of NiO NPs at 18 and 24 h with various doses (125, 250 and 500 mg/kg bw) in female Wistar rats were estimated. There was a significant accumulation of Ni in all organs and blood in the groups of animals treated with NiO NPs. The maximum accumulation of Ni was observed at the 24 h sampling time in tissues such as liver, kidneys, brain, spleen, heart and lungs (Figure 3) . The order of accumulation of Ni was liver > kidneys > spleen>lung> heart > brain. The Ni concentration was significant at 24 h in liver, kidneys, spleen and blood at 250 and 500 mg/kg bw, whereas, at low dose (125 mg/kg bw) only in kidneys (Figure 3b ). This indicated that as the day passed the concentration of particles got diluted. The excretion of Ni in urine was significant at all doses of NiO NPs at all sampling time in a dose-and time-dependent (Figure 3g ). In faeces, the maximum amount of particles i.e. NiO NPs got cleared significantly and clearance was rapid from 18 to 24 h (Figure 3h ).
Discussion
The NiO NPs are considered as one of the most important and used NPs because of their commercial and biomedical applications. Thus, the aim of this study was to investigate the genotoxic ability of NiO NPs after acute treatment through oral route in female Wistar rats. The knowledge of average particle size, crystalline shape, specific surface area, the state of aggregation, surface charge and reactivity of NPs is necessary while examining their nature with regard to their safe use. Appropriate quantitative analytical methods are essential to gather reliable data on the properties of NPs (46) . Therefore, in this study, NiO NPs characterisation was performed. The mean size obtained for NiO NPs by TEM analysis was 15.62 ± 2.59 nm. Particle size is generally considered as the primary factor in toxicity, with smaller the size, particles inclined to be more toxic (47) . The NPs easily penetrate into cells as well as get transferred across epithelial cells and then into the bloodstream and reach sensitive target sites, such as nerve cells due to their small diameter (34) .
Three doses were utilised in the current investigation and the doses were selected based on a range finding study. These dose levels ranged from maximum to little or no toxicity. The highest dose (500 mg/kg) was chosen to produce signs or some indication of toxicity and to obtain detectable amounts of Ni after distribution in the animal organs. Moreover, the low dose of 125 mg/kg bw was chosen to speculate probable human exposure when accidentally exposed to large amounts of NiO NPs. The workers occupationally exposed to the NPs during manufacture may unintentionally get exposed through hands and to the mouth (48) . Moreover, NPs may also be swallowed and get into the gastrointestinal tract (49) .
Genotoxicity is one of the essential parameters to assess the adverse effects of NPs as worries about cancer and genetic diseases are universal. In this study, NiO NPs were found to cause a significant increase in % tail DNA in PBL, liver and kidney tissue cells at 500 mg/kg bw dose in comparison to control, by the comet assay at 18 and 24 h sampling period. At the 250 mg/kg dose, a significant increase in % tail DNA (P < 0.01) was noted at the 24 h sampling period in PBL. Further, at the same dose significant increase in the % tail DNA (P < 0.01) in kidney cells was recorded at both the sampling periods. The observed effect may be due to accumulation of the NPs in kidney tissue as they pass through during the clearance process. However, no significant changes in % tail DNA was noted at any dose or sampling period in liver cells apart from the 500 mg/kg bw dose. This could be due to effective biotransformation or detoxification ability of the liver tissue. The formation of MN in MN-PCEs in bone marrow cells was observed and found to be significant at 250 and 500 mg/kg bw doses of NiO NPs. The % PCEs calculated in the NiO NPs-treated groups did not show any significant change in comparison to the control group, indicating that cell death had not happened in any of the NiO NPs treated groups. Similarly, significant total cytogenetic changes with CA assay were also noted only at the high dose of NiO NPs. Our results are in agreement with an in vitro study of NiO NPs, investigated in A549 cells with cytotoxicity assays such as MTT, LDH and clonogenic assays (50), with comet assay and cellular uptake assay (51) as well as in HEp-2 and MCF-7 cells with MNT, apoptotic DNA ladder assays (52) . There are several direct interactions and indirect mechanisms that can subsequently promote genotoxicity upon exposure with NPs. Direct interaction of NPs occurs due to their potency to attack the vulnerable groups to catalyse break and indirect through inflammation and ROS generation (5, 53) . Hence, the most likely and logical mechanism of genotoxicity upon various sized particles exposure was proposed to be oxidative stress-induced DNA damage (2) . Generation of intracellular ROS in the cells which are metabolically active, could attack DNA base guanine and form 8-OHdG lesions leading to an imbalance in the redox potential of the cellular environment and these 8-OHdG lesions may have mutagenic potential (4) .
ROS generation and oxidative stress have been cited to be one of the possible mechanisms of toxicity related to NP exposure (11, 54) . Moreover, it has been suggested that NPs induced oxidative stress leads to DNA damage and apoptosis (55). Siddiqui et al. (52) provided evidence that NiO NPs induced apoptosis in MCF-7 and HEp-2 cells. Further, the activity of caspase-3 enzyme was greater and caused the fragmentation of DNA in NiO NPs exposed cells. Hence, it could be anticipated that the DNA damage observed in the current study might be due to ROS generation leading to oxidative stress. However, further studies are needed before a firm conclusion could be drawn.
In this study, significant biodistribution of NiO NPs occurred in different tissues, urine and faeces of treated rats. Our data revealed that maximum accumulation in the tissues of NiO NPs was in the liver followed by kidneys. This could be attributed to the NiO NPs biotransformation in the liver and being entrapped in the reticular endothelial system and excreted by the kidneys in vivo. NiO NPs were also observed in the brain which may be because of the presence of sites in the brain that circumvent blood-brain barrier (BBB) and could allow the NiO NPs to enter the brain. Few studies support our results. A study on magnetic NM revealed tissue distribution in various organs including the brain of mice and showed that circumventricular organs within the brain are not protected by the BBB (56) . Similar kinetic studies in mice with different nanosized TiO 2 particles demonstrated its retention in the liver, spleen, kidneys and lung tissues (7) . Similarly, in mice when nano-copper (23.5 nm), ioncopper and micro-copper (17 µm) were treated with a single dose and assessed for distribution in various organs after oral exposure by ICP-MS, the nano-copper treated group, revealed significantly high copper (Cu) content in liver, kidneys and blood. However, the Significantly different from control at *P < 0.05, *** distribution of Cu in micro-copper exposed group was most similar to that of the control group (57) . It can be summarised that characteristics of NPs could have an influence on the toxicokinetic properties of the particles. However, it is still unclear the extent that different NPs characteristics contribute to their kinetics (58) . As can be inferred from our results, the in vivo NiO toxicity was directly connected to the biodistribution and bioaccumulation times, and both were particle size-dependent. Moreover, adverse effects of nano Ni may be closely linked with the size associated capacity to enter in the biological system without any difficulty (59). 
Conclusions
The findings demonstrated that NiO NPs induced genotoxicity at the high dose level. The occurrence of DNA damage and chromosomal changes are the evidence for this effect. Histological analysis indicated that exposure to NiO NPs clearly induced hepatic damage and mild alterations in kidneys. Our results suggested that the orally administered NiO NPs were absorbed via the gastrointestinal tract and were easily able to cross the intestinal barrier and the NPs mainly got deposited in the liver, spleen, kidney, heart and blood. The excretion data showed that small amount of NPs was cleared via urine, whilst most of the NPs were excreted via faeces. The incorporation of Ni in the various tissues was in the range of 0.2-9.4% in the NiO NPs-treated groups. The biodistribution and clearance profile of NPs showed concurrently composite events, and the dynamics of Ni concentration in examined tissues, urine and faeces changed with time. Hence, it can be concluded, that orally administered NiO NPs were easily metabolised and regulated by the body's usual physiological homeostatic mechanism. The bioavailable Ni from exposure of NiO NPs in rats was found to cause significant DNA damage, MN-PCEs and CAs. This indicates that the accumulated Ni lead to significant genotoxicological effects. The present data adds to the information of NiO NPs to be able to interpret its toxicological implication. However, more studies are warranted for careful assessment to ensure the safety of NiO NPs in biomedical applications. Moreover, bioaccumulation of NiO NPs was found to be more pronounced. Nevertheless, there is always a wide scope for more rigorous in vivo toxicity study in order to get a firm and final conclusion. Significantly different from control at ** P < 0.01 and ***
